vs
Side-by-side financial comparison of electroCore, Inc. (ECOR) and Integer Holdings Corp (ITGR). Click either name above to swap in a different company.
electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.
Integer Holdings Corp is a global medical device contract manufacturing partner for leading healthcare and medtech enterprises. It designs, develops and produces high-precision components, assemblies and finished medical devices across core segments including cardiac care, neuromodulation, orthopedics and portable medical products, serving markets across North America, Europe and Asia-Pacific.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | — | ||
| Q3 25 | $8.7M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $6.6M | — | ||
| Q2 24 | $6.1M | — | ||
| Q1 24 | $5.4M | — |
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $-3.7M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-2.5M | — | ||
| Q2 24 | $-2.7M | — | ||
| Q1 24 | $-3.5M | — |
| Q4 25 | 88.4% | — | ||
| Q3 25 | 86.0% | — | ||
| Q2 25 | 87.3% | — | ||
| Q1 25 | 84.9% | — | ||
| Q4 24 | 85.9% | — | ||
| Q3 24 | 83.8% | — | ||
| Q2 24 | 86.3% | — | ||
| Q1 24 | 83.7% | — |
| Q4 25 | -31.8% | — | ||
| Q3 25 | -33.2% | — | ||
| Q2 25 | -47.5% | — | ||
| Q1 25 | -56.9% | — | ||
| Q4 24 | -43.6% | — | ||
| Q3 24 | -40.4% | — | ||
| Q2 24 | -42.2% | — | ||
| Q1 24 | -70.7% | — |
| Q4 25 | -32.8% | — | ||
| Q3 25 | -39.2% | — | ||
| Q2 25 | -49.7% | — | ||
| Q1 25 | -57.4% | — | ||
| Q4 24 | -45.8% | — | ||
| Q3 24 | -38.1% | — | ||
| Q2 24 | -43.2% | — | ||
| Q1 24 | -64.4% | — |
| Q4 25 | $-0.34 | — | ||
| Q3 25 | $-0.40 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.47 | — | ||
| Q4 24 | $-0.37 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.38 | — | ||
| Q1 24 | $-0.53 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
